Latest news
Nationwide Study Tracks Hepatitis B Reactivation and Liver Dysfunction During Infliximab Treatment - Bioengineer.orgBioengineer.org · Sat, 01 Aug 2026 18:58:25 GMTHepatitis B virus infection or reactivation and HBV-related liver dysfunction in patients with inflammatory bowel disease receiving infliximab: a nationwide real-world study - eurekalert.orgeurekalert.org · Thu, 30 Jul 2026 17:55:28 GMT